Australia, Dec. 25 -- Tisento Therapeutics Inc., owns the trademark (2459593) for 'TISENTO THERAPEUTICS' and 'CONCENTRIC ARCS DIVIDE EXPLOSION' till Jan. 31, 2034.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations.] and 42 [Pharmaceutical research and development; conducting pharmaceutical clinical trials for others; pharmaceutical product development.]
Type of Mark: Figurative
Date of Acceptance: Oct. 17
Registration Advertised: Dec. 24
For further details contact Anessa O. Kramer Honigman LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2459593.
Disclaimer: Curated by HT Syndication.
